Mitochondria-Endoplasmic Reticulum Contacts: The Promising Regulators in Diabetic Cardiomyopathy

Area of Science:

• Cardiovascular Research
• Cell Biology
• Endocrinology

Background:

• Diabetic cardiomyopathy (DCM) is a severe diabetes complication leading to heart failure.
• Mitochondrial dysfunction and endoplasmic reticulum (ER) stress are critical in DCM pathogenesis.
• Mitochondria-associated ER membranes (MAMs) are key sites of organelle crosstalk.

Purpose of the Study:

• To review the role of MAMs in the development and progression of DCM.
• To elucidate how MAMs regulate key pathophysiological processes in DCM.
• To discuss MAMs-associated proteins as potential therapeutic targets for DCM.

Main Methods:

• Literature review of studies investigating MAMs in DCM.
• Analysis of evidence linking MAMs to calcium signaling, ER stress, and mitochondrial function.
• Examination of MAMs-associated proteins (MFN2, FUNDC1, GSK3β) in DCM.

Main Results:

• MAMs dysfunction, characterized by altered distance and composition, disrupts cardiomyocyte Ca2+ homeostasis under high glucose.
• MAMs regulate Ca2+ signaling, mitochondrial dynamics, ER stress, autophagy, and inflammation in DCM.
• Specific MAMs-associated proteins are implicated in the pathophysiology of DCM.

Conclusions:

• MAMs play a crucial role in the pathogenesis of diabetic cardiomyopathy.
• Dysfunctional MAMs contribute to DCM through various cellular signaling pathways.
• MAMs-associated proteins represent promising targets for novel DCM therapies.